Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Payables (2020 - 2025)

Bio Essence has reported Payables over the past 6 years, most recently at $37385.0 for Q4 2025.

  • For Q4 2025, Payables rose 110.76% year-over-year to $37385.0; the TTM value through Dec 2025 reached $37385.0, up 110.76%, while the annual FY2025 figure was $37385.0, 110.76% up from the prior year.
  • Payables for Q4 2025 was $37385.0 at Bio Essence, up from $5725.0 in the prior quarter.
  • Over five years, Payables peaked at $500914.0 in Q1 2021 and troughed at $5725.0 in Q3 2025.
  • A 5-year average of $125403.5 and a median of $77081.0 in 2022 define the central range for Payables.
  • Biggest five-year swings in Payables: soared 136388.83% in 2021 and later tumbled 94.73% in 2025.
  • Year by year, Payables stood at $96141.0 in 2021, then plummeted by 53.36% to $44844.0 in 2022, then tumbled by 51.19% to $21889.0 in 2023, then fell by 18.96% to $17738.0 in 2024, then skyrocketed by 110.76% to $37385.0 in 2025.
  • Business Quant data shows Payables for BIOE at $37385.0 in Q4 2025, $5725.0 in Q3 2025, and $17658.0 in Q2 2025.